Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: Case report and review of the literature including WHO spontaneous safety reports

5Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. Case presentation: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given. Conclusions: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost.

Cite

CITATION STYLE

APA

Brockhaus, L., Schmid, Y., Rast, A. C., Rätz Bravo, A. E., Hofmeier, K. S., & Leuppi-Taegtmeyer, A. B. (2019, February 12). Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: Case report and review of the literature including WHO spontaneous safety reports. BMC Pharmacology and Toxicology. BioMed Central Ltd. https://doi.org/10.1186/s40360-019-0289-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free